PALB2 and colorectal carcinoma: Results showed the 3 genes were upregulated in AS lesions (consistent with multi-omics trends), suggesting pro-AS effects; HMMR and PALB2 also showed high expression in CRC, supporting their potential as CRC prognostic markers.